Dong-E-E-Jiao Co.,Ltd.

Shenzhen Stock Exchange 000423.SZ

Dong-E-E-Jiao Co.,Ltd. Receivables for the year ending December 31, 2023: USD 152.53 M

Dong-E-E-Jiao Co.,Ltd. Receivables is USD 152.53 M for the year ending December 31, 2023, a 0.00% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Dong-E-E-Jiao Co.,Ltd. Receivables for the year ending December 31, 2022 was USD 0.00, a -100.00% change year over year.
Dong-E-E-Jiao Co.,Ltd. Receivables for the year ending December 31, 2021 was USD 186.68 M, a -46.49% change year over year.
Dong-E-E-Jiao Co.,Ltd. Receivables for the year ending December 31, 2020 was USD 348.84 M, a 19.82% change year over year.
Dong-E-E-Jiao Co.,Ltd. Receivables for the year ending December 31, 2019 was USD 291.14 M, a -16.81% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Shenzhen Stock Exchange: 000423.SZ

Dong-E-E-Jiao Co.,Ltd.

CEO	Mr. Jie Cheng
IPO Date	July 29, 1996
Location	China
Headquarters	78 Ejiao Street
Employees	3,678
Sector	Health Care
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

Dong-E-E-Jiao Co.,Ltd. produces and sells traditional Chinese medicines, biological drugs, and health food products in China. Dong-E-E-Jiao Co.,Ltd. was founded in 1952 and is based in Liaocheng, China.

Key trends

Past 5 years